Showing results (401-410 of 504) with videos related to

Sort By:
Pageof 51
American Journal of Respiratory Cell and Molecular Biology|October 19, 2013
Dysregulation of galectin-3. Implications for Hermansky-Pudlak syndrome pulmonary fibrosisAndrew R Cullinane, Caroline Yeager, Heidi Dorward, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 5, 2021
Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)Michael Keller, Errol Bush, Joshua M Diamond, et al.
Annals of the American Thoracic Society|October 22, 2021
A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring OxygenChristopher S King, Kevin R Flaherty, Marilyn K Glassberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 24, 2022
Comparison of donor-derived cell-free DNA between single versus double lung transplant recipientsMichael B Keller, Rohan Meda, Sheng Fu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 16, 2023
Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejectionMichael B Keller, Xin Tian, Moon Kyoo Jang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 28, 2025
Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunctionMuhtadi Alnababteh, Junfeng Sun, Rohan Meda, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 5, 2024
Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of diseaseMichael B Keller, David Newman, Muhtadi Alnababteh, et al.
The Journal of Clinical Endocrinology and Metabolism|November 8, 2025
Adverse cardiometabolic impacts of sleep fragmentation and estradiol suppression: An experimental model of menopauseShadab A Rahman, Leilah K Grant, Aviva Y Cohn, et al.
The Lancet. Respiratory Medicine|November 24, 2016
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Pageof 51